KALA BIO, Inc. (KALA) Financials
KALA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 61.1 million | 49.9 million |
2023-06-30 | 66.5 million | 49.0 million |
2023-03-31 | 72.2 million | 48.8 million |
2022-12-31 | 86.8 million | 67.8 million |
KALA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.2 million | 2.4 million |
2023-06-30 | -7.8 million | 1.4 million |
2023-03-31 | -9.8 million | 1.3 million |
2022-12-31 | -13.8 million | 960000 |
KALA Net Income
No data available :(
KALA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 56.1 million | - | 2.2 million |
2023-06-30 | 59.2 million | 33.6 million | - |
2023-03-31 | 63.6 million | 33.3 million | 3000 |
2022-12-31 | 70.5 million | - | 13000 |
KALA Shares Outstanding
KALA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 281000 | 5.6 million | 5.0 million | - |
2023-06-30 | 214000 | 4.3 million | 5.0 million | - |
2023-03-31 | 108000 | 4.0 million | 6.0 million | - |
2022-12-31 | 22000 | 3.3 million | 5.8 million | - |
KALA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 157000 |
2023-06-30 | - | 77000 |
2023-03-31 | - | 87000 |
2022-12-31 | 1.2 million | 2.6 million |
KALA
Price: $7.01
52 week price:
Earnings Per Share: -17.35 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3.0 million
Ebitda: -9.9 millionMarket Capitalization: 20.3 million